See All Slides - tctmd.com

Slides

Presentation TCT 2023

Moderate AS in HFrEF: Time to Treat Is Now

Presenter: Nicolas Van Mieghem

October 24, 2023

Presentation TCT 2023

Best CLTI Case of the Year

Presenter: Hady Lichaa

October 24, 2023

Presentation TCT 2023

Worst CLTI Case of the Year

Presenter: Robert Beasley

October 24, 2023

Presentation TCT 2023

Position 1: Ischemia and Viability Testing Are Overrated – Clinical Judgement Should Guide Patient Management

Presenter: William Lombardi

October 24, 2023

Presentation TCT 2023

We Need More Data: Unanswered Questions, Current and Future Trials

Presenter: Jeffrey Moses

October 24, 2023

Presentation TCT 2023

Revascularization For Patients With Left Ventricular Dysfunction: Are The Trials Still Relevant After a Decade of GDMT and Device Therapy?

Presenter: Clyde Yancy

October 24, 2023

Presentation TCT 2023

Percutaneous Revascularization for Patients With Left Ventricular Dysfunction: REVIVED-BCIS2 – What Do We Know One Year On?

Presenter: Divaka Perera

October 24, 2023

Presentation TCT 2023

Are Progression/Regression Studies “Good Enough” Surrogates for Rcts With Clinical Endpoints?

Presenter: David Erlinge

October 24, 2023

Presentation TCT 2023

Vulnerable Plaque Stabilization: Lessons From Serial Intravascular Imaging Studies

Presenter: Takashi Kubo

October 24, 2023

Presentation TCT 2023

What Is a Vulnerable Plaque? Lessons From Intravascular Imaging

Presenter: Gary Mintz

October 24, 2023

Advertisement

Slides

Moderate AS in HFrEF: Time to Treat Is Now

Best CLTI Case of the Year

Worst CLTI Case of the Year

Position 1: Ischemia and Viability Testing Are Overrated – Clinical Judgement Should Guide Patient Management

We Need More Data: Unanswered Questions, Current and Future Trials

Revascularization For Patients With Left Ventricular Dysfunction: Are The Trials Still Relevant After a Decade of GDMT and Device Therapy?

Percutaneous Revascularization for Patients With Left Ventricular Dysfunction: REVIVED-BCIS2 – What Do We Know One Year On?

Are Progression/Regression Studies “Good Enough” Surrogates for Rcts With Clinical Endpoints?

Vulnerable Plaque Stabilization: Lessons From Serial Intravascular Imaging Studies

What Is a Vulnerable Plaque? Lessons From Intravascular Imaging

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content